← All companies
BOSTON SCIENTIFIC CORP
BSX - CIK 0000885725
Market cap$71.33 B
Rank#239
SEC filings1,009
BOSTON SCIENTIFIC CORP trades as BSX and has a market capitalization of $71.33 B, making it the #239 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $20.07B, up 19.9% from the prior year. This page tracks BOSTON SCIENTIFIC CORP through 1,009 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$20.07BFY 2025
Operating cash flow (latest FY)$4.53BFY 2025
Total assets (latest FY)$43.67BFY 2025
Gross margin69.0%latest FY
Financial performance
Over the last 9 fiscal years BOSTON SCIENTIFIC CORP's revenue grew from $8.39B to $20.07B, a compound annual growth rate of 10.2%.
Key statistics
- Market cap
- $71.33 B
- Share price (derived)market cap / shares outstanding
- $47.99
- EPS (diluted)FY 2025
- $1.94
- Shares outstandingas of 2026-04-29
- 1.49B
- Total equityas of 2026-03-31
- $25.86B
- Cash & equivalentsas of 2026-03-31
- $1.45B
- Dividends paidFY 2024
- $0.00
- Stock buybacksFY 2022
- $0.00
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| SD | - | 2026-05-21 |
| Major company event | 8-K | 2026-05-18 |
| Major company event | 8-K | 2026-05-18 |
| Insider trade | 4 | 2026-05-11 |
| Insider trade | 4 | 2026-05-11 |
Recent press releases
- Boston Scientific announces strategic investment in MiRus LLC - May 18, 20262026-05-18
Find products, medical specialty information, and education opportunities.
- Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results - May 4, 20262026-05-04
Find products, medical specialty information, and education opportunities.
- Boston Scientific announces results for first quarter 2026 - Apr 22, 20262026-04-22
Find products, medical specialty information, and education opportunities.
- Boston Scientific announces conference call discussing first quarter 2026 results - Mar 30, 20262026-03-30
Find products, medical specialty information, and education opportunities.
Similar companies
The largest companies sharing BOSTON SCIENTIFIC CORP's SEC industry classification (surgical & medical instruments & apparatus).
Frequently asked questions
What is BOSTON SCIENTIFIC CORP's market cap?
BOSTON SCIENTIFIC CORP (BSX) has a market capitalization of $71.33 B as of 2026-06-10, ranking #239 among US-listed companies.
How much revenue does BOSTON SCIENTIFIC CORP make?
BOSTON SCIENTIFIC CORP reported revenue of $20.07B for fiscal year 2025, an increase of 19.9% year over year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.